Evidence map›Paper›PMID 30724742›Full record

ArticleJournal of medical Internet research2019

Detecting Potential Adverse Drug Reactions Using a Deep Neural Network Model.

Chi-Shiang Wang, Pei-Ju Lin, Ching-Lan Cheng, Shu-Hua Tai, Yea-Huei Kao Yang, Jung-Hsien Chiang

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  7. Article
  8. Article
  9. pADR: Towards Personalized Adverse Drug Reaction Prediction by Modeling Multi-sourced Data.Proceedings of the ... ACM International Conference on Information & Knowledge Management. ACM International Conference on Information and Knowledge Management · 2023
    Article
  10. Article
  11. Article
  12. Evaluation of four machine learning models for signal detection.Therapeutic advances in drug safety · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chi-Shiang WangDepartment of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0002-8707-279X
Pei-Ju LinDepartment of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0001-6166-1644
Ching-Lan ChengSchool of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0002-7201-8491
Shu-Hua TaiDepartment of Pharmacy, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0003-3398-5582
Yea-Huei Kao YangSchool of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0003-4623-5561
Jung-Hsien ChiangDepartment of Computer Science and Information Engineering, National Cheng Kung University, Tainan, Taiwan.ORCID 0000-0002-4657-6705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdverse drug reactions (ADRs) are common and are the underlying cause of over a million serious injuries and deaths each year. The most familiar method to detect ADRs is relying on spontaneous reports. Unfortunately, the low reporting rate of spontaneous reports is a serious limitation of pharmacovigilance.

objectiveThe objective of this study was to identify a method to detect potential ADRs of drugs automatically using a deep neural network (DNN).

methodsWe designed a DNN model that utilizes the chemical, biological, and biomedical information of drugs to detect ADRs. This model aimed to fulfill two main purposes: identifying the potential ADRs of drugs and predicting the possible ADRs of a new drug. For improving the detection performance, we distributed representations of the target drugs in a vector space to capture the drug relationships using the word-embedding approach to process substantial biomedical literature. Moreover, we built a mapping function to address new drugs that do not appear in the dataset.

resultsUsing the drug information and the ADRs reported up to 2009, we predicted the ADRs of drugs recorded up to 2012. There were 746 drugs and 232 new drugs, which were only recorded in 2012 with 1325 ADRs. The experimental results showed that the overall performance of our model with mean average precision at top-10 achieved is 0.523 and the rea under the receiver operating characteristic curve (AUC) score achieved is 0.844 for ADR prediction on the dataset.

conclusionsOur model is effective in identifying the potential ADRs of a drug and the possible ADRs of a new drug. Most importantly, it can detect potential ADRs irrespective of whether they have been reported in the past.

Indexed as

Neural Networks, ComputerAdverse Drug Reaction Reporting SystemsHumansProhibitinsProhibitinsadverse drug reactionsdeep neural networkdrug representationmachine learningpharmacovigilance

Identifiers

PMID30724742
PMCPMC6381404

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.